Where PBM reform stands across the US
(By: Ella Jeffries for Becker’s Hospital Review) States are advancing legislation to restrict how pharmacy benefit managers operate. In doing
Read More
Part D/Prescription Drugs
IRMAA surprises
The Income-Related Monthly Adjustment Amount (IRMAA) is not a penalty, but rather a pricing structure. IRMAA was created under the
Read More
CVS to sell its troubled long-term care pharmacy
(By: Elizabeth Casolo for Becker’s Hospital Review) CVS Health secured court approval to sell its long-term care pharmacy business, Omnicare,
Read MoreWhat to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge
(Authors: Meredith Freed, Juliette Cubanski, and Elizabeth Williams for The Kaiser Family Foundation Published: May 11, 2026) GLP-1s, a class
Read More
CMS issues another round of Medicare Advantage fines to 13 health plans
(By: Jakob Emerson for Becker’s Hospital Review) CMS has fined 13 health plans a combined $1.5 million for Medicare Advantage
Read MoreThat Discount at the Pharmacy Counter May Pack Hidden Costs
(By Rachel Spears for KFF Health News) Next time you go to the pharmacy, you might be offered a coupon
Read MoreA New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
(By Jackie Fortiér for KFF Health News) Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription
Read MoreAmericans’ Challenges with Health Care Costs
(Authors: Grace Sparks, Lunna Lopes, Alex Montero, Marley Presiado, and Liz Hamel for The Kaiser Family Foundation Published: Apr 30,
Read MoreFDA launches ‘real-time’ clinical trials
(By: Elizabeth Gregerson for Becker’s Hospital Review) The FDA has launched its first two real-time clinical trials in partnership with
Read MoreCMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
(By Juliette Cubanski for The Kaiser Family Foundation published April 23, 2026) The Centers for Medicare & Medicaid Services (CMS)
Read More